|
|
Post by sweedee79 on Feb 26, 2020 20:56:59 GMT -5
Sweedie: Again Naive... you don’t think the sales force has been talking about the 1.5-2 times conversion rate for over 2 yrs? Thank goodness you've been talking about the conversion rate.. but given the experience I've had it makes no sense why the feedback you report has been so dismal.. something isn't right and I dont believe it's Afrezza.. It could be perhaps the cost.. or because patients aren't used to it.. scared of the change.. many things.. but simply saying "it's Afrezza" doesn't sound correct to me. |
|
|
|
Post by joeypotsandpans on Feb 26, 2020 20:57:16 GMT -5
sayhey24 is a type 2 and takes Afrezza. I hear he loves it, btw. There's more T2Ds on twitter I follow that use Afrezza and they also love it. So...apparently it works. but I know at least 5 Type 1's on Afrezza and LOVE IT. I know 2 Pediatric Endos who can't wait to put their patients on it. No one expected Afrezza to be an EARLY SUCCESS when you're going up against the BIG 3 Insulin Makers. I'll tell you one thing....Sanofi (the old CEO) knew the potential of Afrezza. We all know it was going to be a slow climb. Sales are climbing and MNKD is hiring more salespeople. AFREZZA WORKS and people love it. After MNKD gets Pediatric approval and hopefully an improved label.....They will sign a new marketing partner to handle the Type 2 Market. It's not going to happen over night but as long as sales are climbing LIFE IS CAN BE GOOD GREAT The following (below) is posted on the wall next to the patient chairs in the room that I had my office visit today at my endo. This T2 is extremely grateful for both my endo and the original SNY sales rep whose territory he came under. Dr Nguyen at Las Vegas Endocrinology has been prescribing Afrezza now since it's introduction into his practice right after it launched. He is a total advocate of the superior benefits and attributes that come with using Afrezza. I thank a greater power that everyone does not think the same as the OP of this thread. PG I am not sure what happened to you during your time with the company and I will not speculate as to whether you are disgruntled etc. but I can tell you wholeheartedly and without a doubt that Afrezza absolutely has a place with treating the disease in an advantageous fashion in T2 patients as it has been a godsend to me personally. Btw, I pay $100/quarter I have stated my opinion in the past so will not go down that path again regarding the slings and arrows that have unfortunately confronted Al's vision and mission. He absolutely underestimated forces that are nefarious beyond one's wildest dreams all for the almighty dollar. As much of a philanthropist as he was with the vision of helping those afflicted with this disease, among others that he worked on, his mindset was incapable of comprehending just how dark evil and greed could be. In some ways I think he is better off not having had to see it to this point as I can't imagine the frustration he personally would have felt. Having said that, I couldn't help but think as I looked on the wall of my endo's office and saw this that he would have taken some solace and smiled as he sees it from a better place.   |
|
|
|
Post by pguererro on Feb 26, 2020 20:59:46 GMT -5
Oh man...never seen that posted before. Thanks for sharing.
|
|
|
|
Post by sweedee79 on Feb 26, 2020 21:05:49 GMT -5
Wrong on Mike C. Extremely passionate about product and could not get in front of more influential groups. “Doom Porn”😀. Again..double down MNKD is cheap right now!! OH!! So you are a Mike supporter? Sorry but he has lied so many times.. Are you here to tell us Mnkd is going BK? Are you doing us a favor? So does Mike believe the same thing? And yet he continues to spin the story? Why doesn't he at least resign or sell off Afrezza? We aren't a one trick pony.. Tret T is coming. |
|
|
|
Post by pguererro on Feb 26, 2020 21:07:13 GMT -5
Mannkind isn’t hiring anybody new. 2 years ago they had almost 100 sales territories in the US. Today they have mid 70’s and through elimination and sales reps leaving there are always 10-15 openings in the country.
|
|
|
|
Post by pguererro on Feb 26, 2020 21:08:46 GMT -5
Again...pesky facts...like when VDEX was looking into new markets to expand this algorithm. Less VDEX offices today than 3 years ago
|
|
|
|
Post by ktim on Feb 26, 2020 21:09:23 GMT -5
Perhaps if we're prescribed correctly patient retention.would be a whole lot better. According to him that wouldn't change anything, re: "Vdex is a losing proposition" and simply, "it's Afrezza". Doom Porn!!! Why is anyone listening to this chit?Because of reality of disappointing (I've substituted that for a much stronger negative word) sales of Afrezza for years now, combined with the fact that MNKD management provides little data (though somewhat better this last cc), no guidance, and only general hand waving when it comes to generating confidence that Afrezza scripts will have a change in trajectory anytime within the foreseeable future. Also, the naysayers in the first year of Afrezza saying that it would have much market difficulty were absolutely correct, and many now predicting great things were also predicting rapid adoption back then. The latter isn't saying pguererro's position is correct with regard to the future, but saying there is good reason why people may doubt the optimistic story. |
|
|
|
Post by joeypotsandpans on Feb 26, 2020 21:09:25 GMT -5
Oh man...never seen that posted before. Thanks for sharing. You're welcome, the fallout is not because of dosing etc. the fallout is strictly because of LLY and NVO blocking the best new kid off the shelf by substantially undercutting the price which allows United Healthcare and others the ability to deny coverage. It has been ongoing for 3 years and the smarter inside money knew that was going to be a tough mountain to move. I feel for the sales reps as they were fighting an almost impossible battle from day 1. The task at hand remains monumental, as I have mentioned before it takes a long time to take down a wall brick by brick, however, I am optimistic that it will happen. Best of luck to you -J |
|
|
|
Post by golfeveryday on Feb 26, 2020 21:11:17 GMT -5
Wrong on Mike C. Extremely passionate about product and could not get in front of more influential groups. “Doom Porn”😀. Again..double down MNKD is cheap right now!! I’m glad we have people that believe in the product at mnkd. |
|
|
|
Post by sweedee79 on Feb 26, 2020 21:12:09 GMT -5
Again...pesky facts...like when VDEX was looking into new markets to expand this algorithm. Less VDEX offices today than 3 years ago I hear a different story about Vdex.. |
|
|
|
Post by nylefty on Feb 26, 2020 21:12:17 GMT -5
Sweedie: Again Naive... you don’t think the sales force has been talking about the 1.5-2 times conversion rate for over 2 yrs? Wouldn't that violate the FDA rules? That's not what it says on the label. |
|
|
|
Post by pguererro on Feb 26, 2020 21:12:56 GMT -5
Sweedie: Yes I am a Mike C supporter. Call it lies, I’ll call raiding capital and it isn’t over yet. The individual had got off Scott free with no pressure is David Kimball who has done nothing to move the needle with his “influential” friends. Talk about Cush
|
|
|
|
Post by sportsrancho on Feb 26, 2020 21:13:03 GMT -5
I think Vdex has addressed every issue except the cost. And I believe Bill will be talking about that in his next video:-) And offering solutions.
I’ll get back on the other things.
|
|
|
|
Post by pguererro on Feb 26, 2020 21:14:41 GMT -5
NY Lefty. DMAC approved 1.5x in sales material
|
|
|
|
Post by mango on Feb 26, 2020 21:19:14 GMT -5
I don't know where PG is getting his info from but I know at least 5 Type 1's on Afrezza and LOVE IT. I know 2 Pediatric Endos who can't wait to put their patients on it. No one expected Afrezza to be an EARLY SUCCESS when you're going up against the BIG 3 Insulin Makers. I'll tell you one thing....Sanofi (the old CEO) knew the potential of Afrezza. We all know it was going to be a slow climb. Sales are climbing and MNKD is hiring more salespeople. AFREZZA WORKS and people love it. After MNKD gets Pediatric approval and hopefully an improved label.....They will sign a new marketing partner to handle the Type 2 Market. It's not going to happen over night but as long as sales are climbing LIFE IS CAN BE GOOD GREAT The following (below) is posted on the wall next to the patient chairs in the room that I had my office visit today at my endo. This T2 is extremely grateful for both my endo and the original SNY sales rep whose territory he came under. Dr Nguyen at Las Vegas Endocrinology has been prescribing Afrezza now since it's introduction into his practice right after it launched. He is a total advocate of the superior benefits and attributes that come with using Afrezza. I thank a greater power that everyone does not think the same as the OP of this thread. PG I am not sure what happened to you during your time with the company and I will not speculate as to whether you are disgruntled etc. but I can tell you wholeheartedly and without a doubt that Afrezza absolutely has a place with treating the disease in an advantageous fashion in T2 patients as it has been a godsend to me personally. Btw, I pay $100/quarter I have stated my opinion in the past so will not go down that path again regarding the slings and arrows that have unfortunately confronted Al's vision and mission. He absolutely underestimated forces that are nefarious beyond one's wildest dreams all for the almighty dollar. As much of a philanthropist as he was with the vision of helping those afflicted with this disease, among others that he worked on, his mindset was incapable of comprehending just how dark evil and greed could be. In some ways I think he is better off not having had to see it to this point as I can't imagine the frustration he personally would have felt. Having said that, I couldn't help but think as I looked on the wall of my endo's office and saw this that he would have taken some solace and smiled as he sees it from a better place. Joey, that poster is awesome man! Did it come from MannKind? Such a nice, simple, informative and understandable poster. And thank you for sharing your personal experience and thoughts ✊👊 |
|
